Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Tanja R. Zijp"'
Autor:
C Tji Gan, Stephan J. L. Bakker, Daan J Touw, Zamrotul Izzah, Tanja R Zijp, Christoffer Åberg, Job F M van Boven
Publikováno v:
Drugs
Introduction Direct quantification of drug concentrations allows for medication adherence monitoring (MAM) and therapeutic drug monitoring (TDM). Multiple less invasive methods have been developed in recent years: dried blood spots (DBS), saliva, and
Publikováno v:
Journal of Chromatography A. 1702:464086
Autor:
Tanja R Zijp, Tim J Knobbe, Kai van Hateren, Jan Roggeveld, Hans Blokzijl, C Tji Gan, Stephan JL Bakker, Erwin M Jongedijk, TransplantLines Investigators, Daan J Touw
Publikováno v:
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1222:123709. ELSEVIER SCIENCE BV
Traditionally, tacrolimus is assessed in whole blood samples, but this is suboptimal from the perspective that erythrocyte-bound tacrolimus is not a good representative of the active fraction. In this work, a straightforward and rapid method was deve
Autor:
Willemijn J. van Rijt, Derk P. Allersma, Dirk-Jan Reijngoud, Maaike H. Oosterveer, Rick Havinga, Tanja R Zijp, Terry G J Derks, Johan L.K. Van Hove, Ronald J.A. Wanders, M R Heiner-Fokkema, Frédéric M. Vaz, Jirair K. Bedoyan, Michael T. Geraghty
Publikováno v:
Journal of Inherited Metabolic Disease
Journal of Inherited Metabolic Disease, 44(4), 926-938. SPRINGER
Journal of inherited metabolic disease, 44(4), 926-938. Springer Netherlands
Journal of Inherited Metabolic Disease, 44(4), 926-938. SPRINGER
Journal of inherited metabolic disease, 44(4), 926-938. Springer Netherlands
D,L-3-hydroxybutyrate (D,L-3-HB, a ketone body) treatment has been described in several inborn errors of metabolism, including multiple acyl-CoA dehydrogenase deficiency (MADD; glutaric aciduria type II). We aimed to improve the understanding of enan
Publikováno v:
Patient Preference and Adherence. 14:625-634
Purpose: Smart medication adherence monitoring devices can provide objective and granular drug utilization data and help patients engaging with their treatment. In this proof-of-concept study, the acceptability and technical robustness of a novel sma
Autor:
Samiksha Ghimire, Deni Iskandar, Roelina van der Borg-Boekhout, Marina Zenina, Mathieu S. Bolhuis, Huib A.M. Kerstjens, Marieke van Rossum, Daan J. Touw, Tanja R. Zijp, Job F.M. van Boven, Onno W. Akkerman
Publikováno v:
European Respiratory Journal, 60:2201690. EUROPEAN RESPIRATORY SOC JOURNALS LTD
Tuberculosis (TB) is the world-leading cause of infectious disease related mortality, apart from COVID-19 presently [1]. Standard TB treatment for drug-susceptible (DS) TB takes 6–9 months and requires daily intake of multiple medications [1]. Nota
Autor:
Boudewijn J.H. Dierick, Sandra Been-Buck, Titia Klemmeier, Paul Hagedoorn, Susanne J. van de Hei, Huib A.M. Kerstjens, Janwillem W.H. Kocks, Tanja R. Zijp, A. Mireille A. Wessels, Daan J. Touw, Job F.M. van Boven
Publikováno v:
Respiratory Medicine, 201:106940. W B SAUNDERS CO LTD
Pressurized metered dose inhalers are recommended to be used in combination with spacers, yet inhaler technique and adherence are poor. A novel digital "smart" spacer can record spacer use and technique errors and could facilitate personalized educat
Autor:
Jos G. W. Kosterink, Stefan P Berger, Tanja R Zijp, Prashant V Nannan Panday, Martha L Toren-Wielema, Daan J Touw
Publikováno v:
Therapeutic Drug Monitoring, 42(4), 652-653. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring
Publikováno v:
Patient preference and adherence
Purpose Smart medication adherence monitoring devices can provide objective and granular drug utilization data and help patients engaging with their treatment. In this proof-of-concept study, the acceptability and technical robustness of a novel smar
Autor:
Eelko Hak, Yuanyuan Wang, Bob Wilffert, Janwillem W. H. Kocks, Tanja R Zijp, Muh. Akbar Bahar
Publikováno v:
Journal of Antimicrobial Chemotherapy, 73(12). Oxford University Press
Background: As bacterial infections provoke exacerbations, COPD patients may benefit from prophylactic antibiotics. However, evidence regarding their overall benefit-risk profile is conflicting.Objectives: To update previous evidence and systematical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a94d91b95296480822664465876cf6b5
https://research.rug.nl/en/publications/39dfe349-b8e1-482e-a3c3-1f6c31d207f9
https://research.rug.nl/en/publications/39dfe349-b8e1-482e-a3c3-1f6c31d207f9